Form 4: Incyte EVP Paula Swain Reports Stock Disposal for Tax Obligations

Paula J Swain, EVP of Human Resources at Incyte Corp, reported disposing of 5,560 shares of common stock to cover tax withholding obligations.

Summary

• On July 2, 2024, Paula J Swain, the EVP of Human Resources at Incyte Corp, disposed of 5,560 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations related to the settlement of previously reported restricted stock units (RSUs) and earned performance shares.
• The shares were disposed of at a price of $59.02 per share.
• Following the transaction, Swain beneficially owns 79,347 shares of Incyte common stock, which includes 22,692 unvested shares from previously reported RSUs and performance stock units.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so the sentiment is neutral.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like Paula Swain, transact in their company's stock. These filings provide transparency to the market regarding the buying and selling activities of those with privileged information.

Comparison to Industry Standards

• Executive compensation practices, including the use of RSUs and performance shares, are common across the biotechnology and pharmaceutical industries.
• Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize similar equity-based compensation plans for their executives.
• The tax withholding obligations arising from the vesting of these equity awards often lead to stock disposal transactions, which are routinely disclosed via Form 4 filings.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disposal of shares to cover tax obligations.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates